RFID Implants Need Better Privacy Protection


Archived Published: 19 October 2004 ID: G00124544

Analyst(s):

  Free preview of Gartner research

Summary

The U.S. Federal Drug Administration (FDA) has approved a radio frequency identification (RFID) device for use in humans. But widespread adoption will have to wait until serious privacy concerns are addressed.

News Analysis

Event

On 13 October 2004, Applied Digital announced that the FDA has approved its surgically implantable VeriChip RFID device for medical applications in the United States. VeriChip contains a microchip transponder, encoded with a unique verification number, that can be surgically implanted in a human patient. The implanted microchip can then be scanned to identify the patient and allow access to his or her medical records via the Internet.

Analysis

The use of RFID implants has already given rise to significant privacy concerns. Some of the most widely publicized fears — such as the possibility that the implants could be used to track individuals in public places — are largely unfounded. Like security badges and electronic subway tokens, these devices are designed to work only across short distances. Moreover, although these devices are wireless, they communicate using only magnetic fields.

Nonetheless, security concerns — both legitimate and illegitimate — will continue to limit adoption of RFID implants for human use. (They are already widely used to identify household pets.) For example, the devices hold what amount to serial numbers, and will give this information to virtually any reader. An implanted person could therefore be involuntarily, and perhaps unknowingly, identified. Gartner believes these devices will not achieve widespread adoption until secure devices become available. Secure devices would allow access to confidential information on third-party servers only under authority of the device's user.

Recommendation: Until privacy-enabled devices are produced, use RFID implants only when the potential benefits outweigh privacy concerns.

Analytical Source: Martin Reynolds, Gartner Research

Recommended Reading and Related Research

(You may need to sign in or be a Gartner client to access the documents referenced in this FirstTake.)

© 2004 Gartner, Inc. and/or its Affiliates. All Rights Reserved. Reproduction and distribution of this publication in any form without prior written permission is forbidden. The information contained herein has been obtained from sources believed to be reliable. Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartners research may discuss legal issues related to the information technology business, Gartner does not provide legal advice or services and its research should not be construed or used as such. Gartner shall have no liability for errors, omissions or inadequacies in the information contained herein or for interpretations thereof. The opinions expressed herein are subject to change without notice.

Why Gartner

Gartner delivers the technology-related insight you need to make the right decisions, every day.

Find out more

Call +1 800 213 4848 or contact us

to become a Gartner client.